scholarly journals Comparative evaluation of Transient Evoked Oto-acoustic Emissions and Brainstem Evoked Response Audiometry as screening modality for hearing impairment in neonates

2007 ◽  
Vol 59 (1) ◽  
pp. 15-18 ◽  
Author(s):  
Rajiv Dhawan ◽  
N. N. Mathur
2020 ◽  
Vol 34 (3) ◽  
pp. 109-117
Author(s):  
Aparna Aradhana ◽  
Gadadhar Sarangi ◽  
Prasant Saboth ◽  
Radha Tripathy

Objectives: To find out the incidence of hearing impairment in Neonatal Intensive Care Unit (NICU)-admitted newborns and to correlate between several risk factors. Design: Prospective observational study. Setting: In a tertiary teaching hospital of Odisha between October 2014 and October 2016. Study population: 100 newborns delivered in the institution and admitted in NICU with usual indications and risk factors that underwent otoacoustic emission 1 and 2 (OAE1, OAE2) and Brainstem Evoked Response Audiometry (BERA). Results: 84 babies in OAE1 and 86 babies in OAE2 got “pass” results. In BERA test, 92 babies got normal waveform. 7 (13.7%) of 51 premature babies, 5 (38.5%) of 13 very low birth weight babies, 7 (17.5%) of 40 babies receiving ototoxic medication for >5 days, 7 (31.8%) of 22 babies with hyperbilirubinemia, 6 (42.9%) of 14 babies with sepsis, 5 (20%) of 20 babies with birth asphyxia, 3 (60%) of 5 babies under mechanical ventilation for >5 days, 1 baby with ear abnormality, and 1 (50%) out of 2 babies with congenital infections had hearing impairment and statistically significant association with abnormal OAE and BERA test. Conclusion: There is high incidence of hearing loss in NICU-admitted newborns. OAE and BERA both should be performed for complete evaluation of hearing. Important risk factors are elaborated. Predischarge hearing assessment in NICU is most important.


Author(s):  
Pradeep Kumar Singh ◽  
Nishant Kumar ◽  
Dheeraj Kumar ◽  
Nisha Shrivastava ◽  
Abhishek Kumar

Background: A child’s normal speech and language development depends on the ability to hear. Early detection of hearing loss by screening at or shortly after birth and appropriate intervention are critical to speech, language and cognitive development. Objectives were to describe socio-epidemiological profile of newborns for hearing loss screening by transient evoked oto-acoustic emissions (TEOAE) and brainstem evoked response audiometry (BERA) in Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India during 18 months period (June 2015- November 2016), and to study association between hearing loss and risk factors.Methods: This prospective study was done on 4356 newborns for hearing screening by TEOAE in maternity ward and NICU and BERA in those noted “refer” on retest TEOAE at RIMS, Ranchi, Jharkhand, India during the period of 18 months (June 2015 - November 2016). Follow- up done by visits and phone calls. Templates were generated in MS excel sheet and data analysis was done using SPSS software (version 20).Results: Study showed 3.90/1000 newborns were noted “refer” on retest TEOAE. Hearing loss (BERA- Fail) is slightly more common in males (2.20/1000 newborns), of rural areas (2.44/1000 newborns), tribal ethnicity (2.75/1000  newborns) and those delivered by lower section caesarean section (LSCS) (4.47/1000 newborns). Hearing loss noted in 2.07/1000 newborns. Among high risk newborns 21.41/1000 newborns were noted “refer” on retest TEOAE and 11.53 were found BERA fail.Conclusions: Hearing loss was 21.71 times more common in newborns associated with high risk factors, mainly low birth weight and preterm newborns.


2006 ◽  
Vol 121 (7) ◽  
pp. 639-643 ◽  
Author(s):  
N N Mathur ◽  
R Dhawan

Objective: To formulate an alternative strategy for universal infants hearing screening in an Indian tertiary referral hospital with a high delivery rate, which could be extended to similar situations in other developing countries. The system should be able to diagnose, in a timely fashion, all infants with severe and profound hearing losses.Methods: One thousand newborn were randomly selected. All underwent testing with transient evoked oto-acoustic emissions (TEOAE) in the first 48 hours of life. All TEOAE failures were followed up and repeat tests were performed at three weeks, three months and six months of age. Infants with acceptable TEOAE results at any of the four ages were discharged from the study. Infants with unacceptable TEOAE results at all the four ages underwent brainstem evoked response audiometry and oto-endoscopy. The ‘pass rate’ for TEOAE testing was calculated for all four ages. The time taken to perform TEOAE and brainstem evoked response audiometry was recorded for all subjects. These recordings were statistically analysed to find the most suitable strategy for universal hearing screening in our hospital.Results: The pass rate for TEOAE was 79.0 per cent at ≤48 hours, 85.0 per cent at three weeks, 97.0 per cent at three months and 98.0 per cent at six months. The average time taken to perform the test was 12 minutes for TEOAE and 27 minutes for brainstem evoked response audiometry. Obstructed and collapsed external auditory canals were the two factors that significantly affected the specificity of TEOAE in infants ≤48 hours old.Conclusion: The concept of screening all neonates within the first 48 hours of life is impractical because the specificity of TEOAE is lowest at that age. Many false positive results are generated, such that a larger number must undergo brainstem evoked response audiometry, wasting time and resources. This can easily be avoided by delaying TEOAE screening until three months of age, when it has a substantially lower false positive outcome. We expect that implementation of this alternative strategy in our hospital will maximise the benefits of such a programme.


2015 ◽  
Vol 21 (2) ◽  
pp. 134 ◽  
Author(s):  
Ramanathan Thirunavukarasu ◽  
GaneshKumar Balasubramaniam ◽  
RameshBabu Kalyanasundaram ◽  
Gitanjali Narendran ◽  
Sajee Sridhar

2021 ◽  
Vol 29 (2) ◽  
pp. 182-188
Author(s):  
Deepika Goswami ◽  
Saurabh Srivastava ◽  
Anuja Bhargava ◽  
Syed M Faiz ◽  
Zeba Siddiqi ◽  
...  

Introduction Diabetes has become a global epidemic. Hearing loss has been long associated with diabetes. Brainstem Evoked Response Audiometry (BERA) is an objective, non-invasive, electro diagnostic test that not only evaluates the functional integrity of the subcortical auditory pathway but also provides topo-diagnosis of hearing loss. This study aims to identify the role BERA in detecting hearing loss early in diabetic patients.Materials and Methods In this study a total of 210 patients were taken and subjected to blood glucose levels followed by PTA were divided into two groups. Group I (n=105) consisted of diabetic patients with sensorineural hearing loss (SNHL) and Group II (n=105) had age and sex matched non-diabetics with SNHL. All the patients were evaluated with BERA.Results All the patients were subjected to Brain Stem Evoked Response Audiometry (BERA). Absolute latency of Wave I, III, V, I-III, III-V and I-V were assessed for both the ears. In both ear Absolute latency were significantly higher in diabetics as compared to non-diabetic patientsConclusion The findings of present study showed that the severity of hearing loss was significantly higher in diabetic patients as compared to non-diabetic controls. Level of glycemic control showed a possible link with severity of hearing loss.


Sign in / Sign up

Export Citation Format

Share Document